Pretax income is the income that a company earns before paying income taxes. Kingworld Medicines Group's pretax income for the
six
months ended in Dec. 2023 was HK$40 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$103 Mil.
Kingworld Medicines Group's pretax margin was 6.89%.
During the past 13 years, Kingworld Medicines Group's highest Pretax Margin was 9.51%. The lowest was 6.52%. And the median was 7.73%.
Kingworld Medicines Group Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kingworld Medicines Group's Pre-Tax Income
For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kingworld Medicines Group's Pre-Tax Income Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Kingworld Medicines Group's Pre-Tax Income falls into.
Kingworld Medicines Group Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Kingworld Medicines Group's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$103 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kingworld Medicines Group (HKSE:01110) Pre-Tax Income Explanation
Kingworld Medicines Group's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Kingworld Medicines Group's highest Pretax Margin was 9.51%. The lowest was 6.52%. And the median was 7.73%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kingworld Medicines Group Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Kingworld Medicines Group's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Kingworld Medicines Group (HKSE:01110) Business Description
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01110 has been successfully added to your 